Upcoming Seminars

Joint Meeting of the Basel Epidemiology Seminar & Basel Biometric Section

Patient Preferences – methods and relevance for medicinal decision making


Date and time:                     

  • November 22, 2018
  • 14:00-17:00


  • Basel,  F. Hoffmann-la Roche AG, Building 683-0B110
  • Viaduktstrasse 33, CH-4051 Basel (nearby Basel SBB railway station)


  • There are no registration fees.
  • Registration closed


Meeting chair: Daniel Rosenberg

 14:00 – 14:10         Welcome

Daniel Rosenberg (BES) and Uli Burger (BBS)

14:10 – 14:30         Patient Preference Studies – Introduction

Conny Berlin, Novartis

14:30- 14:50          A randomised crossover study to evaluate patient preference for Rituximab SC or IV (Stuart Osborne, Roche)

14:50-15:10           Patient Preference Study: sequential vs. initial combination therapy in a rare disease (Evan Davies, Actelion)

15:10-15:20           Questions

15:20-15:40           Coffee break

15:40-16:10           Patient Preference Study conducted in early drug development in COPD patients (Florian Gutzwiller, Novartis)

16:10-16:40           Value assessment frameworks: incorporating preference and clinical data in HTA

(Axel Mühlbacher, Prof. of Health Economics and Health Care Management at Hochschule Neubrandenburg, Adjunct Professor and CHPIR Senior Research Fellow, Duke University)

16:40-17:00           Discussion & closure

Leave a Reply

Your email address will not be published. Required fields are marked *